1 Cancer Research Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK 2 Division of Epidemiology and Public Health, University of ...

Dr E Hnizdo, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS PB 163, Morgantown, WV 26505, USA BACKGROUND A study was undertaken to establish the chronic effect of ...

1 Department of Diagnostic Imaging, Turku University Hospital, Turku, Finland 2 Department of Pediatrics, Turku University Hospital, Turku, Finland Correspondence to: Dr O Ruuskanen, Department of ...

Applied Immunobiology and Transplantation Research Group, Institute of Cellular Medicine, University of Newcastle, Newcastle upon Tyne, UK Correspondence to Dr A J Fisher, Applied Immunobiology and ...

1 Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, Colorado, USA 2 Division of Psychosocial Medicine, National Jewish Health, Denver, Colorado, USA 3 ...

Correspondence to Dr Tetsuro Araki, Department of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02215, USA; ...

Background: Quadriceps weakness and loss of muscle mass predict mortality in chronic obstructive pulmonary disease (COPD). It was hypothesised that a reduced quadriceps cross-sectional area could be ...

Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent. Research question Are UPF associated with an increased risk of lung cancer ...

Background Previous studies have reported an association between warm temperature and asthma hospitalisation. They have reported different sex-related and age-related vulnerabilities; nevertheless, ...

Academic Unit of Respiratory Medicine, St Bartholomew’s and Royal London School of Medicine and Dentistry, London EC1A 7BE, UK Correspondence to: Professor J A Wedzicha, Academic Unit of Respiratory ...

Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...

Introduction Breathlessness is a common cause of hospital admission globally and is associated with high mortality, ...